We examined the effect of 1α-hydroxyvitamin D3 treatment on hyperbilirubinemia induced by intravenous bilirubin infusion in wild-type mice and found that VDR activation did not increase the rate of clearance of exogenous bilirubin (unpublished data). This evidence concerns the gene VDR and Hyperbilirubinemia.